12-Oct-2026 12:36:47

JUBLPHARMA : BOARD APPROVES NCD ISSUANCE UP TO RS 800 CR

• Board approved issuance of up to 80,000 NCDs of face value ₹1 L each, aggregating up to ₹800 Cr on private placement basis • NCDs are secured / unsecured, listed, rated, redeemable and transferable, with tenure up to five years from deemed date of allotment • NCDs proposed to be listed on BSE • Board also approved seeking members' special resolution via postal ballot for non-convertible debt securities up to ₹2,500 Cr outstanding at any point in time over one year • Coupon/interest to be discovered during bidding process; payment frequency annually, monthly or early redemption as applicable

Jubilant Pharmova Ltd

← Back to feed